What the Biden Administration Could Do Now to Protect Abortion Rights
The most urgent step the federal government can take is to ensure access to medication abortion.
The most urgent step the federal government can take is to ensure access to medication abortion.
Consolidated healthcare systems – even cross market systems – don’t have to raise their prices to have anticompetitive effects. They can leverage their size by […]
Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the […]
The American Hospital Association and Association of American Medical Colleges have filed an amicus brief in support of the New Jersey health systems that are […]
In closing its Grail acquisition before U.S. and European regulators sign off, Illumina is taking a chance the deal will pass regulatory muster. It’s a […]
AbbVie will not be pursued any further by the US government over allegations that it used ‘sham’ litigation to keep competition to its AndroGel testosterone […]
An order reflects the administration’s growing embrace of warnings by some economists that declining competition is hobbling the economy’s vitality.
An order reflects the administration’s growing embrace of warnings by some economists that declining competition is hobbling the economy’s vitality.
The Federal Trade Commission is opposing Illumina’s proposed $7.1 billion Grail acquisition, arguing that it will reduce competition for multi-cancer early detection tests. Illumina disagrees […]
Copyright © 2024 | WordPress Theme by MH Themes